🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Gastrooesophageal Cancer

GastrOesophageal Tumor, Immune Microenvionnment (GOTIM) NCT05644431n/a1 site📍 Lyon Centre Leon Berard Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma NCT06644352NA1 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: different thoracic surgical approaches Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers NCT05205343n/a4 sites📍 Rochester📍 Houston📍 Tokyo M.D. Anderson Cancer Center · Tests: Standard of Care, Control Group A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites📍 New York📍 Huntersville📍 San Antonio Arvinas Inc. · Tests: ARV-6723, Pembrolizumab, SOC A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites📍 Goodyear📍 Phoenix📍 Duarte IDEAYA Biosciences · Tests: IDE892, IDE397 Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer NCT04511039Phase 11 site📍 Buffalo Roswell Park Cancer Institute · Tests: Trifluridine and Tipiracil Hydrochloride, Talazoparib Tosylate A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors NCT07488676Phase 1, Phase 221 sites📍 Birmingham📍 Los Angeles📍 Miami Astellas Pharma Global Development, Inc. · Tests: ASP546C Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors NCT06239194Phase 1, Phase 26 sites📍 Denver📍 Miami📍 Boston ModeX Therapeutics, An OPKO Health Company · Tests: MDX2001 Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer NCT06687291n/a1 site📍 Huddinge Karolinska Institutet Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. NCT07217704Phase 319 sites📍 Cerritos📍 Duarte📍 Irvine SOFIE · Tests: [18F]FAPI-74 PET/CT Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer NCT07392892Phase 2, Phase 3102 sites📍 Atascadero📍 Burbank📍 Encino Pfizer · Tests: PF-08634404, Chemotherapy, Nivolumab A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer NCT06921837Phase 1, Phase 216 sites📍 Darlinghurst📍 Westmead📍 Birtinya Bolt Biotherapeutics, Inc. · Tests: BDC-4182 Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors NCT07151040Phase 1, Phase 24 sites📍 Villejuif📍 Barcelona📍 Madrid One-carbon Therapeutics AB · Tests: TH9619 Sample Collection for Ongoing Research and Product Evaluation Study NCT07318051n/a1 site📍 Austin Natera, Inc. Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy NCT06065371Phase 11 site📍 Detroit Henry Ford Health System · Tests: Capecitabine, Sacituzumab govetican Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer NCT06497569NA2 sites📍 Tampa📍 Chapel Hill H. Lee Moffitt Cancer Center and Research Institute · Tests: Dietitian Consultation, Survey, Fitbit Data Collection, Referral to Dietitian, Social Determinants of Health Survey (SD… CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1 NCT04455282n/a2 sites📍 Cologne📍 Münster Heinrich-Heine University, Duesseldorf Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer NCT06468280Phase 22 sites📍 Shanghai📍 Shanghai Shanghai Zhongshan Hospital · Tests: Local treatment (Surgical), PD-1 Monoclonal Antibody, XELOX/SOX Chemotherapy Regimen, Local Treatment (Non-surgical), T… Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease NCT06253650Phase 21 site📍 Milan Gruppo Oncologico del Nord-Ovest · Tests: Experimental, Control Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer NCT05965479Phase 214 sites📍 Guildford📍 Coventry📍 Belfast University of Southampton · Tests: Trastuzumab deruxtecan Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma NCT07529808Phase 1, Phase 23 sites📍 Duarte📍 Santa Monica📍 Fairfax BigHat Biosciences, Inc. · Tests: BHB810 PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer NCT06906887Phase 21 site📍 Milwaukee Medical College of Wisconsin · Tests: Induction Chemotherapy (modified FLOT or modified FOLFOX-6), Chemotherapy, Conventional Radiation, Pulsed Low-Dose-Rate… A Phase 1/1b Study of IAM1363 in HER2 Cancers NCT06253871Phase 153 sites📍 La Jolla📍 Los Angeles📍 Aurora Iambic Therapeutics, Inc · Tests: IAM1363 BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer NCT07629609Phase 21 site📍 Copenhagen Barbara Malene Fischer · Tests: [68Ga]Ga-FAPI-46 A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers NCT06422403Phase 21 site📍 Singapore National University Hospital, Singapore · Tests: Extended Dosing Interval - A, Extended Dosing Interval - B, Extended Dosing Interval - C, Standard of Care - A, Standar… Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer NCT04688801NA1 site📍 Jinan The Second Hospital of Shandong University · Tests: Chemotherapy Drugs, Cancer, Immunotherapy A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors NCT06695845Phase 228 sites📍 Prescott📍 Littleton📍 Fort Myers Jazz Pharmaceuticals · Tests: Zanidatamab The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES) NCT06138223NA22 sites📍 Amsterdam📍 Utrecht📍 's-Hertogenbosch Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Exercise intervention, Nutrition intervention Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer NCT06028737Phase 2, Phase 32 sites📍 Vilnius📍 Kyiv Ukrainian Society of Clinical Oncology · Tests: Docetaxel, Oxaliplatin, Leucovorin, Fluorouracil A Phase 1 Study of the Safety and Tolerability of CTX-10726 NCT07419841Phase 18 sites📍 Phoenix📍 Jacksonville📍 Rochester Compass Therapeutics · Tests: CTX-10726
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy